NUP98 and acute myeloid leukemia: Importantly, FLT3–ITD were found in heterogeneous diseases including NPM1-mutated or CBF AML which have shown to have a highly favorable outcome but also in NUP98-rearranged and WT1-mutated AML which are associated with poor prognosis.